Skip to main content
Erschienen in: Journal of Nuclear Cardiology 3/2021

16.06.2020 | EDITORIAL

Predicting left ventricular dyssynchrony: Can nuclear cardiology bring us closer “In Sync”?

verfasst von: Karen Kan, MD, Lawrence M. Phillips, MD, FASNC

Erschienen in: Journal of Nuclear Cardiology | Ausgabe 3/2021

Einloggen, um Zugang zu erhalten

Excerpt

Multiple imaging modalities including baseline electrocardiography and echocardiography have been investigated for independent prediction of left ventricular mechanical dyssynchrony (LVMD). This cardiac finding is extremely important given the impact that it has both on worsening of cardiac status as well as treatment focus. Cardiac resynchronization therapy (CRT) is a Class I indication for patients with advanced heart failure and the following criteria: severely depressed left ventricular ejection fraction (≤ 35%), left bundle branch block (LBBB) with wide QRS duration on electrocardiogram (≥ 150 ms), and New York Heart Association (NYHA) class II, III, or IV symptoms.1 Although improvement in functional status and quality of life is seen in many patients, it has been reported that up to 30% of patients who meet AHA/ACC guidelines for implantation of CRT fail to respond.2-5 However, what is missing from the patient profile above is confirmation of LVMD. It has been observed that patients demonstrating LVMD are more likely to respond favorably to CRT suggesting that perhaps more refined criteria may be needed to predict which subset of patients will benefit from CRT.6,7 It has also been demonstrated that LVMD may exist in patients with right bundle branch block (RBBB) who may not fulfill the typical criteria for CRT implantation, but who may nevertheless, benefit from resynchronization.8,9 Prior studies have shown that LVMD can be accurately evaluated by gated single-photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI).10,11 However, the exact pathogenesis of LVMD remains poorly understood. …
Literatur
1.
Zurück zum Zitat Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA 3rd, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO, Tracy CM, Epstein AE, Darbar D, DiMarco JP, Dunbar SB, Estes NA 3rd, Ferguson TB Jr, Hammill SC, Karasik PE, Link MS, Marine JE, Schoenfeld MH, Shanker AJ, Silka MJ, Stevenson LW, Stevenson WG, Varosy PD, American College of Cardiology F, American Heart Association Task Force on Practice G and Heart Rhythm S. ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 2012;2013(61):e6-75. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA 3rd, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO, Tracy CM, Epstein AE, Darbar D, DiMarco JP, Dunbar SB, Estes NA 3rd, Ferguson TB Jr, Hammill SC, Karasik PE, Link MS, Marine JE, Schoenfeld MH, Shanker AJ, Silka MJ, Stevenson LW, Stevenson WG, Varosy PD, American College of Cardiology F, American Heart Association Task Force on Practice G and Heart Rhythm S. ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 2012;2013(61):e6-75.
2.
Zurück zum Zitat Achilli A, Sassara M, Ficili S, Pontillo D, Achilli P, Alessi C, De Spirito S, Guerra R, Patruno N, Serra F. Long-term effectiveness of cardiac resynchronization therapy in patients with refractory heart failure and “narrow” QRS. J Am Coll Cardiol 2003;42:2117-24.CrossRef Achilli A, Sassara M, Ficili S, Pontillo D, Achilli P, Alessi C, De Spirito S, Guerra R, Patruno N, Serra F. Long-term effectiveness of cardiac resynchronization therapy in patients with refractory heart failure and “narrow” QRS. J Am Coll Cardiol 2003;42:2117-24.CrossRef
3.
Zurück zum Zitat Chung ES, Leon AR, Tavazzi L, Sun JP, Nihoyannopoulos P, Merlino J, Abraham WT, Ghio S, Leclercq C, Bax JJ, Yu CM, Gorcsan J 3rd, St John Sutton M, De Sutter J, Murillo J. Results of the predictors of response to CRT (PROSPECT) trial. Circulation 2008;117:2608-16.CrossRef Chung ES, Leon AR, Tavazzi L, Sun JP, Nihoyannopoulos P, Merlino J, Abraham WT, Ghio S, Leclercq C, Bax JJ, Yu CM, Gorcsan J 3rd, St John Sutton M, De Sutter J, Murillo J. Results of the predictors of response to CRT (PROSPECT) trial. Circulation 2008;117:2608-16.CrossRef
4.
Zurück zum Zitat Suffoletto MS, Dohi K, Cannesson M, Saba S, Gorcsan J 3rd. Novel speckle-tracking radial strain from routine black-and-white echocardiographic images to quantify dyssynchrony and predict response to cardiac resynchronization therapy. Circulation 2006;113:960-8.CrossRef Suffoletto MS, Dohi K, Cannesson M, Saba S, Gorcsan J 3rd. Novel speckle-tracking radial strain from routine black-and-white echocardiographic images to quantify dyssynchrony and predict response to cardiac resynchronization therapy. Circulation 2006;113:960-8.CrossRef
5.
Zurück zum Zitat Young JB, Abraham WT, Smith AL, Leon AR, Lieberman R, Wilkoff B, Canby RC, Schroeder JS, Liem LB, Hall S, Wheelan K, Multicenter InSync ICDRCETI. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: The MIRACLE ICD Trial. JAMA 2003;289:2685-94.CrossRef Young JB, Abraham WT, Smith AL, Leon AR, Lieberman R, Wilkoff B, Canby RC, Schroeder JS, Liem LB, Hall S, Wheelan K, Multicenter InSync ICDRCETI. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: The MIRACLE ICD Trial. JAMA 2003;289:2685-94.CrossRef
6.
Zurück zum Zitat Bax JJ, Bleeker GB, Marwick TH, Molhoek SG, Boersma E, Steendijk P, van der Wall EE, Schalij MJ. Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy. J Am Coll Cardiol 2004;44:1834-40.CrossRef Bax JJ, Bleeker GB, Marwick TH, Molhoek SG, Boersma E, Steendijk P, van der Wall EE, Schalij MJ. Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy. J Am Coll Cardiol 2004;44:1834-40.CrossRef
7.
Zurück zum Zitat Bax JJ, Marwick TH, Molhoek SG, Bleeker GB, van Erven L, Boersma E, Steendijk P, van der Wall EE, Schalij MJ. Left ventricular dyssynchrony predicts benefit of cardiac resynchronization therapy in patients with end-stage heart failure before pacemaker implantation. Am J Cardiol 2003;92:1238-40.CrossRef Bax JJ, Marwick TH, Molhoek SG, Bleeker GB, van Erven L, Boersma E, Steendijk P, van der Wall EE, Schalij MJ. Left ventricular dyssynchrony predicts benefit of cardiac resynchronization therapy in patients with end-stage heart failure before pacemaker implantation. Am J Cardiol 2003;92:1238-40.CrossRef
8.
Zurück zum Zitat Sillanmaki S, Aapro S, Lipponen JA, Tarvainen MP, Laitinen T, Hedman M, Hamalainen H and Laitinen T. Electrical and mechanical dyssynchrony in patients with right bundle branch block. J Nucl Cardiol 2018. Sillanmaki S, Aapro S, Lipponen JA, Tarvainen MP, Laitinen T, Hedman M, Hamalainen H and Laitinen T. Electrical and mechanical dyssynchrony in patients with right bundle branch block. J Nucl Cardiol 2018.
9.
Zurück zum Zitat Sillanmaki S, Aapro S, Lipponen JA, Tarvainen MP, Laitinen T, Hedman M, Hamalainen H, Laitinen T. Electrical and mechanical dyssynchrony in patients with right bundle branch block. J Nucl Cardiol 2020;27:621-30.CrossRef Sillanmaki S, Aapro S, Lipponen JA, Tarvainen MP, Laitinen T, Hedman M, Hamalainen H, Laitinen T. Electrical and mechanical dyssynchrony in patients with right bundle branch block. J Nucl Cardiol 2020;27:621-30.CrossRef
10.
Zurück zum Zitat Azizian N, Rastgou F, Ghaedian T, Golabchi A, Bahadorian B, Khanlarzadeh V, Azizian Z, Haghjoo M. LV dyssynchrony assessed with phase analysis on gated myocardial perfusion SPECT can predict response to CRT in patients with end-stage heart failure. Res Cardiovasc Med 2014;3:e20720.PubMedPubMedCentral Azizian N, Rastgou F, Ghaedian T, Golabchi A, Bahadorian B, Khanlarzadeh V, Azizian Z, Haghjoo M. LV dyssynchrony assessed with phase analysis on gated myocardial perfusion SPECT can predict response to CRT in patients with end-stage heart failure. Res Cardiovasc Med 2014;3:e20720.PubMedPubMedCentral
11.
Zurück zum Zitat Henneman MM, Chen J, Dibbets-Schneider P, Stokkel MP, Bleeker GB, Ypenburg C, van der Wall EE, Schalij MJ, Garcia EV, Bax JJ. Can LV dyssynchrony as assessed with phase analysis on gated myocardial perfusion SPECT predict response to CRT? J Nucl Med 2007;48:1104-11.CrossRef Henneman MM, Chen J, Dibbets-Schneider P, Stokkel MP, Bleeker GB, Ypenburg C, van der Wall EE, Schalij MJ, Garcia EV, Bax JJ. Can LV dyssynchrony as assessed with phase analysis on gated myocardial perfusion SPECT predict response to CRT? J Nucl Med 2007;48:1104-11.CrossRef
13.
Zurück zum Zitat Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Chang AR, Cheng S, Delling FN, Djousse L, Elkind MSV, Ferguson JF, Fornage M, Khan SS, Kissela BM, Knutson KL, Kwan TW, Lackland DT, Lewis TT, Lichtman JH, Longenecker CT, Loop MS, Lutsey PL, Martin SS, Matsushita K, Moran AE, Mussolino ME, Perak AM, Rosamond WD, Roth GA, Sampson UKA, Satou GM, Schroeder EB, Shah SH, Shay CM, Spartano NL, Stokes A, Tirschwell DL, VanWagner LB, Tsao CW, American Heart Association Council on E, Prevention Statistics C and Stroke Statistics S. Heart disease and stroke statistics-2020 update: A report from the American Heart Association. Circulation 2020;141:e139-596.PubMed Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Chang AR, Cheng S, Delling FN, Djousse L, Elkind MSV, Ferguson JF, Fornage M, Khan SS, Kissela BM, Knutson KL, Kwan TW, Lackland DT, Lewis TT, Lichtman JH, Longenecker CT, Loop MS, Lutsey PL, Martin SS, Matsushita K, Moran AE, Mussolino ME, Perak AM, Rosamond WD, Roth GA, Sampson UKA, Satou GM, Schroeder EB, Shah SH, Shay CM, Spartano NL, Stokes A, Tirschwell DL, VanWagner LB, Tsao CW, American Heart Association Council on E, Prevention Statistics C and Stroke Statistics S. Heart disease and stroke statistics-2020 update: A report from the American Heart Association. Circulation 2020;141:e139-596.PubMed
Metadaten
Titel
Predicting left ventricular dyssynchrony: Can nuclear cardiology bring us closer “In Sync”?
verfasst von
Karen Kan, MD
Lawrence M. Phillips, MD, FASNC
Publikationsdatum
16.06.2020
Verlag
Springer International Publishing
Erschienen in
Journal of Nuclear Cardiology / Ausgabe 3/2021
Print ISSN: 1071-3581
Elektronische ISSN: 1532-6551
DOI
https://doi.org/10.1007/s12350-020-02226-w

Weitere Artikel der Ausgabe 3/2021

Journal of Nuclear Cardiology 3/2021 Zur Ausgabe

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Strenge Blutdruckeinstellung lohnt auch im Alter noch

30.04.2024 Arterielle Hypertonie Nachrichten

Ältere Frauen, die von chronischen Erkrankungen weitgehend verschont sind, haben offenbar die besten Chancen, ihren 90. Geburtstag zu erleben, wenn ihr systolischer Blutdruck < 130 mmHg liegt. Das scheint selbst für 80-Jährige noch zu gelten.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Dihydropyridin-Kalziumantagonisten können auf die Nieren gehen

30.04.2024 Hypertonie Nachrichten

Im Vergleich zu anderen Blutdrucksenkern sind Kalziumantagonisten vom Diyhdropyridin-Typ mit einem erhöhten Risiko für eine Mikroalbuminurie und in Abwesenheit eines RAS-Blockers auch für ein terminales Nierenversagen verbunden.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.